Y
Yasuaki Dohi
Researcher at Nagoya Gakuin University
Publications - 126
Citations - 3695
Yasuaki Dohi is an academic researcher from Nagoya Gakuin University. The author has contributed to research in topics: Blood pressure & Population. The author has an hindex of 28, co-authored 118 publications receiving 2900 citations. Previous affiliations of Yasuaki Dohi include Nagoya City University & Toyota.
Papers
More filters
Journal ArticleDOI
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Satoshi Umemura,Hisatomi Arima,Shuji Arima,Kei Asayama,Yasuaki Dohi,Yoshitaka Hirooka,Takeshi Horio,Satoshi Hoshide,Shunya Ikeda,Toshihiko Ishimitsu,Masaaki Ito,Sadayoshi Ito,Yoshio Iwashima,Hisashi Kai,Kei Kamide,Yoshihiko Kanno,Naoki Kashihara,Yuhei Kawano,Toru Kikuchi,Kazuo Kitamura,Takanari Kitazono,Katsuhiko Kohara,Masataka Kudo,Hiroo Kumagai,Kiyoshi Matsumura,Hideo Matsuura,Katsuyuki Miura,Masashi Mukoyama,Satoko Nakamura,Takayoshi Ohkubo,Yusuke Ohya,Takafumi Okura,Hiromi Rakugi,Shigeyuki Saitoh,Hirotaka Shibata,Tatsuo Shimosawa,Hiromichi Suzuki,Shori Takahashi,Kouichi Tamura,Hirofumi Tomiyama,Takuya Tsuchihashi,Shinichiro Ueda,Yoshinari Uehara,Hidenori Urata,Nobuhito Hirawa +44 more
TL;DR: The story of the life and times of Toshihiko Umemura and his family in the years leading up to and including his death.
Journal ArticleDOI
Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study
Kazuaki Shimamoto,Naoyuki Hasebe,Sadayoshi Ito,Kazuomi Kario,Kenjiro Kimura,Yasuaki Dohi,Yuhei Kawano,Hiromi Rakugi,Masatsugu Horiuchi,Tsutomu Imaizumi,Yusuke Ohya +10 more
TL;DR: A higher dose of nifedipine CR was associated with greater efficacy and a safety profile similar to that of the currently approved dose (40 mg q.i.d.) in Japanese patients with essential hypertension, and it may offer a valuable treatment choice for patients who do not achieve target BP levels with standard treatment.
Journal ArticleDOI
Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis—a randomized study
Akihiko Takahashi,Hiroyuki Takase,Takayuki Toriyama,Tomonori Sugiura,Yutaka Kurita,Ryuzo Ueda,Yasuaki Dohi +6 more
TL;DR: Cedesartan therapy significantly reduces cardiovascular events and mortality in patients on chronic maintenance haemodialysis and therefore improves the prognosis of these patients.
Journal ArticleDOI
Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure
T Goto,Hiroyuki Takase,Takayuki Toriyama,Tomonori Sugiura,Katsutoshi Sato,R. Ueda,Yasuaki Dohi +6 more
TL;DR: Findings suggest that MLC-I, H-FABP, CK-MB, and TnT may be used as reliable markers for the evaluation of the severity of congestive heart failure.
Journal ArticleDOI
Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events.
TL;DR: It is proposed that salt sensitivity of BP and excess salt intake have important roles in the genesis of the cardiorenal connection and are the keys to understanding the connections between cardiovascular and renal complications.